COVID-19: Different Strains of Corona, Vaccine Efficacy, Treatment,
Medical Ethics, and Future Perspectives

Sonia      Singh; Ashima      Ahuja; Raghavan      Ramankutty; Sarada      Ramaswamy
doi:10.2174/0126667975265095231019065626
Abstract

In the pandemic era of COVID-19, there is an urgent need to develop a safe and effective vaccine to prevent different variants/strains of COVID-19. The developed vaccine must have the potency of sustained/controlled drug release into the body. The emergency is reinforced by detailed scientific knowledge in the genomic field, which eases the rapid development of an effective vaccine using novel approaches that enhance large-scale production, manufacturing, and testing analysis. This manuscript concludes the various variants of COVID-19 and types of COVID-19 vaccines available in the pharmaceutical market with their pricing details and even discusses their efficacy against various COVID-19 variants. Global partnerships with other pharmaceutical industries and countries have played a significant role in distributing and deploying the vaccine among the masses. Social support, relaxation exercise, psychological counseling, parents’ role, psychiatrist help, family support, yoga, meditation, exercise, and a balanced diet reduce psychosocial stress and promote health.
Graphical Abstract

[1]
The difference between vaccine efficacy and effectiveness | World Economic Forum  Available from:    weforum.org
          (Accessed on: 3 October, 2023)
        

[2]
World Health Organization The effects of virus variants on COVID-19 vaccines 2021. Available from:  https://www.who.int/news-room/feature-stories/detail/the-effects-of-virus-variants-on-COVID-19-vaccines
        (Accessed on: March 1,2021)
        

[3]
World Health Organization. Coronavirus  Available from :   https://www.who.int/health-topics/coronavirus#tab=tab_1

[4]
Pathak N. Coronavirus and COVID-19: What you should know 2021.  Available from:    https://www.webmd.com/lung/coronavirus
          (Accessed on: April 19, 2021)
        

[5]
COVID-19 vaccine effectiveness affected by variants, GlobalData Healthcare. 2021.  Available from:   https://www.pharmaceutical-technology.com/comment/COVID-19-vaccine-effectiveness-affected-by-variants/
          (Accessed on: March 3, 2021)
        

[6]
COVID-19 vaccines and new virus strains, university of maryland medical system. 2021.  Available from:   https://www.umms.org/coronavirus/COVID-vaccine/facts/strain
           (Accessed on: February 7, 2021).
         

[7]
Hewings-Martin Y, Cohut M. New SARS-CoV-2 variants: How can vaccines be adapted?, Medical News Today. 2021.  Available from:     https://www.medicalnewstoday.com/articles/new-sars-cov-2-variants-how-can-vaccines-be-adapted.st
           (Accessed 16 April,2023).
         

[8]
Vishnoi A. SARS-COV-2: What are variants & strains and why are they important? The Economic Times. 2021.  Available from:   https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/sars-cov-2-what-are-variants-amp-strains-and-why-are-they-important/vaccine-efficacy-on-variants/slideshow/82494517.cms
          (Accessed on: 10 April, 2023).
        

[9]
Leo L. Pfizer, Moderna vaccines show limited effectiveness on strain in India, Mint. 2021.  Available from: https://www.livemint.com/news/india/pfizer-moderna-jabs-show-reduced-antibody-response-against-variant-from-india-11620819709502.html
          (Accesed on: May 13, 2021).
        

[10]
Roberts M. What are the India, Brazil, South Africa and UK variants? BBC News. 2021.  Available from:   https://www.bbc.com/news/health-55659820
          (Accessed on: June 6,2021).
        

[11]
Terry M. Comparing COVID-19 vaccines: Timelines, types and prices, biospace. 2021.  Available from:      https://www.biospace.com/article/comparing-COVID-19-vaccines-pfizer-biontech-moderna-astrazeneca-oxford-j-and-j-russia-s-sputnik-v/
           (Accessed on: June 15, 2021)
         

[12]
COVID variants: Latest on the Indian, UK, South African and Brazilian variants, Heart Matters magazine 2021.  Available from:   https://www.bhf.org.uk/informationsupport/heart-matters-magazine/news/coronavirus-and-your-health/COVID-variant
           (Accessed on: June 18, 2021).
         

[13]
Corey L, Mascola JR, Fauci AS, Collins FS. A strategic approach to COVID-19 vaccine R&D. Science  2020; 368(6494): 948-50.
 [http://dx.doi.org/10.1126/science.abc5312] [PMID:  32393526]

[14]
Khuroo MS, Khuroo M, Khuroo MS, Sofi AA, Khuroo NS. COVID-19 vaccines: a race against time in the middle of death and devastation! J Clin Exp Hepatol  2020; 10(6): 610-21.
 [http://dx.doi.org/10.1016/j.jceh.2020.06.003] [PMID:  32837093]

[15]
Lurie N, Saville M, Hatchett R, Halton J. Developing COVID-19 vaccines at pandemic speed. N Engl J Med  2020; 382(21): 1969-73.
 [http://dx.doi.org/10.1056/NEJMp2005630] [PMID:  32227757]

[16]
Perappadan BS. Coronavirus | Covaxin phase-1 trial results show promising results, The Hindu 2020. Available from:       https://www.thehindu.com/sci-tech/science/coronavirus-covaxin-phase-1-trial-results-show-vaccine-is-safe/article33348040.ece
          (Accessed on: December 16, 2020).
        

[17]
U.S. National Library of Medicine. Clinical Trial For SARS-CoV-2 Vaccine (COVID-19) 2021. Available from:      https://clinicaltrials.gov/ct2/show/NCT04582344
        (Accessed on:February 17, 2021).
                  

[18]
Pfizer and Biontech announce publication of results from landmark phase 3 Trial of BNT162b2 COVID-19 vaccine candidate in The New England Journal of Medicine Business Wire 2020.https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-announce-publication-results-landmark

[19]
Sumirtanurdin R, Barliana MI. Coronavirus disease 2019 vaccine development: an overview. Viral Immunol  2021; 34(3): 134-44.
 [http://dx.doi.org/10.1089/vim.2020.0119] [PMID:  32985963]

[20]
McCarthy N. How effective are the COVID-19 vaccines?, Statista 2021. Available from:   https://www.statista.com/chart/23510/estimated-effectiveness-of-COVID-19-vaccine-candidates/
          (Accessed on: February 2, 2021).
        

[21]
McCarthy N. The cost per jab of COVID-19 vaccine candidates,Statista 2020. Available from:  https://www.statista.com/chart/23658/reported-cost-per-dose-of-COVID-19-vaccines/
           (Accessed on: December 1, 2020).
        

[22]
McCarthy N. The COVID-19 vaccination race, statista 2021. Available from:   https://www.statista.com/chart/23833/COVID-19-vaccination-doses-per-100-people/
          (Accessed on: May 17, 2021).
        

[23]
COVID: South Africa halts AstraZeneca vaccine rollout over new variant, BBC NEWS  Available from:     https://www.bbc.com/news/world-africa-55975052
          (Accessed on: February 8, 2021).
        

[24]
Mazza MG, De Lorenzo R, Conte C, et al. Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors. Brain Behav Immun  2020; 89: 594-600.
 [http://dx.doi.org/10.1016/j.bbi.2020.07.037] [PMID:  32738287]

[25]
Country readiness for COVID-19 vaccines  Available from :  https://www.who.int/news-room/feature-stories/detail/country-readiness-for-COVID-19-vaccines
          (Accessed on: 10 April, 2023).
        

[26]
Adamu AA, Jalo RI, Habonimana D, Wiysonge CS. COVID-19 and routine childhood immunization in Africa: Leveraging systems thinking and implementation science to improve immunization system performance. Int J Infect Dis  2020; 98: 161-5.
 [http://dx.doi.org/10.1016/j.ijid.2020.06.072] [PMID:  32592908]

[27]
Mills MC, Salisbury D. The challenges of distributing COVID-19 vaccinations. EClinicalMedicine  2021; 31: 100674.
 [http://dx.doi.org/10.1016/j.eclinm.2020.100674] [PMID:  33319186]

[28]
Republic of Sudan Federal Ministry of Health National deployment and vaccination plan for COVID-19 vaccines  Available from:   https://reliefweb.int/sites/reliefweb.int/files/resources/sudan_COVID_nvdp_final.pdf
          (Accessed on: 10 April, 2023).
        

[29]
Forman R, Shah S, Jeurissen P, Jit M, Mossialos E. COVID-19 vaccine challenges: What have we learned so far and what remains to be done? Health Policy  2021; 125(5): 553-67.
 [http://dx.doi.org/10.1016/j.healthpol.2021.03.013] [PMID:  33820678]

[30]
 Available from:   
          https://www.mohfw.gov.in/pdf/COVID19VaccineOG111Chapter16.pdf
          (Accessed on: 25 December, 2022).
        

[31]
 Available from:    https://apps.who.int/iris/bitstream/handle/10665/111548/9789241506892_eng.pdf?sequence=1
           (Accessed on: 18 April, 2023).
         

[32]
World Health Organization Emergency use listing procedure,Geneva 2020. Available from:   https://www.who.int/medicines/publications/EULprocedure.pdf
           (Accessed 18 January, 2023).
         

[33]
 Available from:   https://www.who.int/teams/regulation-prequalification/eul
          (Accessed on: 18 January, 2023).
        

[34]
 Available from:   https://www.who.int/teams/regulation-prequalification/eul/COVID-19
           (Accessed on: 31 March, 2023).
         

[35]
World Health Organization List of stringent regulatory authorities (SRAs), Geneva  Available from: https://www.who.int/initiatives/who-listed-authority-reg-authorities/SRAs
         (Accessed on: 5 February, 2023).
       

[36]
 Available from: https://apps.who.int/iris/bitstream/handle/10665/111548/9789241506892_eng.pdf?sequence=1
           (Accessed on: 12 Jan, 2023).
         

[37]
 Available from: https://www.who.int/publications/m/item/roadmap-for-evaluation-of-astrazeneca-azd1222-vaccine-against-COVID-19
           (Accessed on:26 April, 2023)
         

[38]
 Available from:  https://www.who.int/biologicals/expert_committee/PIP_Non-producer_guide_BS_final-working_version-19102016-clean.pdf
           (Accessed on: 29 January, 2023).
         

[39]
World Health Organization Annex 5, Guidelines on regulatory preparedness for provision of marketing authorization of human pandemic influenza vaccines in non-vaccine-producing countries  Available from:  https://www.who.int/biologicals/expert_committee/WHO_TRS_1004_web_Annex_7.pdf?ua=1
           (Accessed on: 25 December, 2022).
         

[40]
 Available from:   https://static.mygov.in/rest/s3fs-public/mygov_161725058451307401.pdf
          (Accessed on: 25 December, 2022).
        

[41]
evised guidelines for implementation of national COVID vaccination program  Available from:  https://www.mohfw.gov.in/pdf/RevisedVaccinationGuidelines.pdf
           (Accessed 15 January, 2023).
         

[42]
WHO monitoring COVID-19 vaccination interim guidance country readiness and delivery considerations for the collection and use of vaccination data. Interim Guidance 2021.

[43]
Australian Institute of Health and Welfare COVID-19 Vaccination Program Implementation Plan Aboriginal and Torres Strait Islander Peoples Canberra: Australia’s Welfare Snapshots.  2019.

[44]
OECD. Enhancing public trust in COVID-19 vaccination: The role of governments. 2021; 9-27.

[45]
Coronavirus disease (COVID-19): Vaccines  Available from :  https://www.seruminstitute.com/product_covishield.php
          (Accessed on: 10 April, 2023).
        

[46]
COVAXIN® - India's First Indigenous COVID-19 Vaccine  Available from :    https://www.bharatbiotech.com/covaxin.html
          (Accessed on: 10 December, 2022).
        

[47]
Mounting evidence suggests Sputnik COVID vaccine is safe and effective  Available from :   https://www.nature.com/articles/d41586-021-01813-2
          (Accessed 30 December, 2022).
        

[48]
Covaxin: India approves two COVID vaccines for children under 12  Available from : https://www.bbc.com/news/world-asia-india-55748124
          (Accessed on: 30 April, 2023).
        

[49]
Sputnik V. Vaccine 2023. Available from :   https://www.precisionvaccinations.com/vaccines/sputnik-v-vaccine
           (Accessed on: 13 May, 2023).
         

[50]
 Available from :  https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/Moderna.html
           (Accessed 16 December, 2022).
         

[51]
 Available from : https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-COVID-19/moderna-COVID-19-vaccine
         (Accessed on: 28 April, 2023).
       

[52]
Ministry of Health and Family Welfare, Govt of India. COVID-19 Vaccines operational guidelines. 2020; 45-6.

[53]
Guidelines on regulatory preparedness for provision of marketing authorization of human pandemic influenza vaccines in nonvaccine- producing countries, Annex 7, TRS No 1004  Available from : https://www.who.int/publications/m/item/trs1004-annex7-pandemic-influenza-vaccine
          (Accessed on: 2 May, 2023).
        

[54]
World Health Organization Preventing and managing COVID-19 across long-term care services  Available from : https://www.who.int/publications/i/item/WHO-2019-nCoV-Policy_Brief-Long-term_Care-2020.1
           (Accessed on: 2 May, 2023).
         

[55]
World Health Organization. COVID-19 vaccination: Supply and logistics guidance, Interim Guidance 2021.

[56]
World Health Organization Strategic Advisory Group of Experts on Immunization (SAGE) 2020. Available from :   https://www.who.int/groups/strategic-advisory-group-of-experts-on-immunization
           (Accessed on: 8 May, 2023).
         

[57]
World Health Organization The Country-led Assessment for Prioritization on Immunization (CAPACITI) project: Decide health decisions Hub.  2020. Available from :https://www.who.int/docs/default-source/immunization/vaccine_impact_value/en_capaciti_decision-support_manual_v2.1.pdf?sfvrsn=c070a27_20
         (Accessed on: 5 May, 2023)
       

[58]
You are what you eat: Choose foods that boost immunity and fight infection  Available from : https://www.uchealth.com/en/media-room/COVID-19/boost-immunity-with-food
          (Accessed on: 28 December, 2022).
        

[59]
 Available from : https://www.ayush.gov.in/
         (Accessed on: 29 December,2022)
       

[60]
Gurumallu SC, Javaraiah R. Bioactives in disease prevention and health promotion: Exploiting combinatorial effects. Curr Bioact Compd  2021; 17(4): 299-317.
 [http://dx.doi.org/10.2174/1573407216999200612103526]

[61]
Mishra A, Chandel AKS, Bhalani DV, Shrivastava R. Importance of dietary supplements to the health. Curr Nutr Food Sci  2021; 17(6): 583-600.
 [http://dx.doi.org/10.2174/1573401316999200901111519]

[62]
Shoaib A, Azmi L, Shukla I, Alqahtani SS, Alsarra IA, Shakeel F. Properties of ethnomedicinal plants and their bioactive compounds: Possible use for COVID-19 prevention and treatment. Curr Pharm Des  2021; 27(13): 1579-87.
 [http://dx.doi.org/10.2174/1381612826666201106092021] [PMID:  33155905]

[63]
Bibi S, Sarfraz A, Mustafa G, et al. The impact of traditional plants and their secondary metabolites in the discovery of COVID-19 treatment. Curr Pharm Des  2021; 27(9): 1123-43.
 [http://dx.doi.org/10.2174/1381612826666201118103416] [PMID:  33213320]

[64]
Black pepper may hold the key for Corona fighting drug: Study  Available from :   https://www.downtoearth.org.in/news/science-technology/black-pepper-may-hold-the-key-for-corona-fighting-drug-study-73822
          (Accessed on: 13 April, 2023).
        

[65]
Say goodbye to stress and anxiety with these natural herbs  Available from :   https://www.freepressjournal.in/health/say-goodbye-to-stress-and-anxiety-with-these-natural-herbs
            (Accessed on: 10 May,2023).
          

[66]
National Clinical Management Protocol based on Ayurveda and Yoga for management of COVID-19 Ministery of Ayush, Govt of India,  3-6. Available from :    https://www.ayush.gov.in/docs/ayush-Protocol-COVID-19.pdf
           (Accessed on: 20 April, 2023).
         

[67]
Coronavirus (COVID-19) treatment  Available from :https://www.webmd.com/lung/covid-treatment-home-hospital#1
          (Accessed on: 15 March, 2023).
        

[68]
Coronavirus disease 2019 (COVID-19) 2019. Available from :  https://www.mayoclinic.org/diseases-conditions/coronavirus/diagnosis-treatment/drc-20479976
          (Accessed on: 31 December, 2022).
        

[69]
Kumar S, Sudha S, Chopra M, Khan F, Sharma K. Physical exercise and yoga: As an alternative approach towards COVID-19 management. Curr Tradit Med  2021; 7(5): e220321192407.
 [http://dx.doi.org/10.2174/2215083807666210322152352]

[70]
Kumar Mishra N. Social distancing as social engineering & health management: Applied ethics perspective to global management & strategic leadership. Research in Globalization  2020; 2: 100032.
 [http://dx.doi.org/10.1016/j.resglo.2020.100032]

[71]
Mishra NK, Baba MH. Delayed care is no care: COVID-19 impact on cancer patients at ethical perspective. JK Pract  2021; 26: 59-66.

[72]
Gopichandran V. Clinical ethics during the COVID-19 pandemic: Missing the trees for the forest. Indian J Med Ethics  2020; 5(3): 182-7.
 [http://dx.doi.org/10.20529/IJME.2020.053] [PMID:  32546461]

[73]
Chew C, Ko D. Medical ethics in the era of COVID‐19: Now and the future. Respirology  2020; 25(10): 1033-4.
 [http://dx.doi.org/10.1111/resp.13927] [PMID:  32761691]

[74]
Ethics and COVID-19  Available from : https://www.who.int/teams/health-ethics-governance/diseases/covid-19
          (Accessed on:25 April, 2023).
        

[75]
Nelson SE. COVID-19 and ethics in the ICU. Crit Care  2020; 24(1): 519.
 [http://dx.doi.org/10.1186/s13054-020-03250-5] [PMID:  32843069]

[76]
Robert R, Kentish-Barnes N, Boyer A, Laurent A, Azoulay E, Reignier J. Ethical dilemmas due to the COVID-19 pandemic. Ann Intensive Care  2020; 10(1): 84.
 [http://dx.doi.org/10.1186/s13613-020-00702-7] [PMID:  32556826]

[77]
Xiang YT, Zhao YJ, Liu ZH, et al. The COVID-19 outbreak and psychiatric hospitals in China: managing challenges through mental health service reform. Int J Biol Sci  2020; 16(10): 1741-4.
 [http://dx.doi.org/10.7150/ijbs.45072] [PMID:  32226293]

[78]
Cao W, Fang Z, Hou G, et al. The psychological impact of the COVID-19 epidemic on college students in China. Psychiatry Res  2020; 287: 112934.
 [http://dx.doi.org/10.1016/j.psychres.2020.112934] [PMID:  32229390]

[79]
 Available from:    https://www.COVID19INDIA.org/
          (Accessed on:25 March, 2023).
        

[80]
What might the third wave of COVID-19 in India look like?  Available from:  https://www.news-medical.net/news/20210829/What-might-the-third-wave-of-COVID-19-in-India-look-like.aspx
           (Accessed on: 25 April, 2023).
         

[81]
Here’s what India’s third wave of COVID-19 could look like  Available from :  https://www.thenewsminute.com/article/here-s-what-india-s-third-wave-COVID-19-could-look-154143
          (Accessed on: 25 March, 2023).
        

[82]
 Available from :   https://economictimes.indiatimes.com/news/india/COVID-third-wave-could-peak-between-oct-nov-intensity-expected-to-be-1/4-of-second-wave/articleshow/85766983.cms
          (Accessed on: 25 December,2022).
        

[83]
 Available from :  https://www.india.com/news/india/third-wave-of-corona-in-india-expected-date-aiims-director-randeep-gulerias-big-statement-people-should-not-ignore-read-details-4889979/
         (Accessed on: 25 December, 2022).
       

[84]
 Available from : https://www.downtoearth.org.in/news/africa/COVID-19-in-africa-nearly-half-the-nations-going-through-deadlier-3rd-wave-77986
          (Accessed on: 25 March, 2023).
        

[85]
Third wave of COVID-19 impacts countries around the globe  Available from : https://www.pih.org/article/third-wave-COVID-19-impacts-countries-around-globe
          (Accessed on: 8 May, 2023).
        

[86]
Gupta J, Gupta R. Bridging the gap between community mental health and COVID-19 patients: impact on healthcare. Bull Env. Pharmacol and Life Sci  2020; 9: 143-50.

[87]
Gupta R, Gupta J. Analyzing the impact of corona virus on mental health and clinical decision-making of elderly patients. Bull Env. Pharmacol and Life Sci  2020; 9: 136-42.

[88]
Gupta J. Analysis of clinical management and improved early symptom protection of coronavirus in adult patients. Bull Env. Pharmacol and Life Sci  2020; 9: 25-31.

[89]
Wang C, Pan R, Wan X, et al. Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in China. Int J Environ Res Public Health  2020; 17(5): 1729.
 [http://dx.doi.org/10.3390/ijerph17051729] [PMID:  32155789]

[90]
Narasimha VL, Shukla L, Mukherjee D, et al. Complicated alcohol withdrawal-an unintended consequence of COVID-19 lockdown. Alcohol Alcohol  2020; 55(4): 350-3.
 [http://dx.doi.org/10.1093/alcalc/agaa042] [PMID:  32400859]

[91]
Park SC, Park YC. Mental health care measures in response to the 2019 novel coronavirus outbreak in Korea. Psychiatry Investig  2020; 17(2): 85-6.
 [http://dx.doi.org/10.30773/pi.2020.0058] [PMID:  32093458]

[92]
Venkatesh A, Edirappuli S. Social distancing in COVID-19: what are the mental health implications? BMJ  2020; 369: m1379.
 [http://dx.doi.org/10.1136/bmj.m1379] [PMID:  32253182]

[93]
Liu JJ, Bao Y, Huang X, Shi J, Lu L. Mental health considerations for children quarantined because of COVID-19. Lancet Child Adolesc Health  2020; 4(5): 347-9.
 [http://dx.doi.org/10.1016/S2352-4642(20)30096-1] [PMID:  32224303]

[94]
Zandifar A, Badrfam R. Iranian mental health during the COVID-19 epidemic. Asian J Psychiatr  2020; 51: 101990.
 [http://dx.doi.org/10.1016/j.ajp.2020.101990] [PMID:  32163908]

[95]
Dawel A, Shou Y, Smithson M, et al. The effect of COVID-19 on mental health and wellbeing in a representative sample of Australian adults. Front Psychiatry  2020; 11: 579985.
 [http://dx.doi.org/10.3389/fpsyt.2020.579985]

[96]
Taquet M, Luciano S, Geddes JR, Harrison PJ. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry  2021; 8(2): 130-40.
 [http://dx.doi.org/10.1016/S2215-0366(20)30462-4] [PMID:  33181098]
Rights & Permissions Print Cite
Journal Information
For Authors
For Editors
For Reviewers
Explore Articles
Open Access
Open Access Articles
For Visitors
DOI https://dx.doi.org/10.2174/0126667975265095231019065626	Print ISSN 2666-7967
Publisher Name Bentham Science Publisher	Online ISSN 2666-7975
Coronaviruses

COVID-19: Different Strains of Corona, Vaccine Efficacy, Treatment, Medical Ethics, and Future Perspectives

Abstract Play Pause

Graphical Abstract

Related Journals

Related Books

Abstract
